AZNIX
Price
$12.30
Change
+$0.02 (+0.16%)
Updated
Oct 17 closing price
Net Assets
4.76B
RLEFX
Price
$38.98
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.62B
Interact to see
Advertisement

AZNIX vs RLEFX

Header iconAZNIX vs RLEFX Comparison
Open Charts AZNIX vs RLEFXBanner chart's image
Virtus Income & Growth Inst
Price$12.30
Change+$0.02 (+0.16%)
VolumeN/A
Net Assets4.76B
American Funds American Balanced R5E
Price$38.98
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.62B
AZNIX vs RLEFX Comparison Chart in %
View a ticker or compare two or three
VS
AZNIX vs. RLEFX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZNIX is a Buy and RLEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 266B vs. AZNIX (4.76B). AZNIX pays higher dividends than RLEFX: AZNIX (2.22) vs RLEFX (1.92). AZNIX was incepted earlier than RLEFX: AZNIX (19 years) vs RLEFX (10 years). AZNIX (0.91) is less costly to investors than RLEFX (0.39). AZNIX is a more actively managed with annual turnover of: 76.00 vs. RLEFX (44.00). RLEFX has a lower initial minimum investment than AZNIX: RLEFX (250) vs AZNIX (1000000). RLEFX annual gain was more profitable for investors over the last year : 8.94 vs. AZNIX (5.86). RLEFX return over 5 years is better than : 43.26 vs. AZNIX (9.15).
AZNIXRLEFXAZNIX / RLEFX
Total Expense Ratio0.900.39231%
Annual Report Gross Expense Ratio0.910.39233%
Fund Existence19 years10 years-
Gain YTD5.99914.81940%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.76B266B2%
Annual Yield % from dividends2.221.92116%
Returns for 1 year5.868.9466%
Returns for 3 years26.0451.3951%
Returns for 5 years9.1543.2621%
Returns for 10 years31.09N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRXP3.180.14
+4.61%
NRX Pharmaceuticals
ELAN21.420.90
+4.39%
Elanco Animal Health
SBC4.200.03
+0.60%
SBC Medical Group Holdings Incorporated
AIHS1.960.01
+0.51%
Senmiao Technology Limited
WLYB36.95-0.41
-1.10%
John Wiley & Sons